Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company vTv Therapeutics Inc.
DescriptionOrally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today